Euractiv (Advocacy Lab)
EU Perspectives
European Biotechnology Magazine
APM Market Access
EU PERSPECTIVES - Patients could pay the price as MEPs vote to delay who foots the bill for cleaning Europe's water. Parliament backed a temporary suspension of new costs for drugmakers and cosmetics firms. The vote split the assembly, pitting fears of medicine shortages against warnings that citizens will pay for pollution instead. Read more
EURACTIV - Belgium used the 16th June meeting of EU health ministers in Luxembourg to press for a united European front on medicine prices, urging member states to coordinate their response to US "most favoured nation" (MFN) pricing demands. Read more
EU PERSPECTIVES - It kills nearly ten million people a year and is expected to rise sharply in the coming decades. Cancer has for the first time been elevated to the top tier of global political priorities. G7 leaders issued an unprecedented heads-of-state declaration dedicated solely to the disease. Read more
EURACTIV - Belgium ranks among the European leaders in pharmaceutical research, patents, exports and jobs. Yet only half of the innovative medicines approved at the European level between 2021 and 2024 are available to Belgian patients, and those that do arrive take on average a year and a half. Read more
